Valuation for Oncocyte (id:5921 OCX)
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|---|---|---|
| Trailing P/E | 3.00 |
|
|
| Forward P/E | -1.29 |
|
|
| Price to sales | 52.95 |
|
|
| Price to book | 3.15 |
|
|
| Enterprise to revenue | 43.63 |
|
|
| Enterprise to ebitda | -1.44 |
|
|